CBOE three-lens brief
Evidence-based stock research on CBOE. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 24.1pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 24.1pp over 30 days.
- Analyst mean target $313.71 — 18% above current (14 analysts).
- Earnings scheduled 2026-07-31.
CBOE closed at $265.14 (-1.01%) as of 2026-07-10. Market cap: $27.75B. P/E (trailing) 22.6. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $313.71 — 18% above current (14 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 24.1pp over 30 days.. Last quarter: Revenue $728.90M, net income $384.10M, free cash flow $1.00B. Watching for: 2026-07-31 earnings release (20 days out).
Why three lenses on CBOE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CBOEacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CBOE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CBOE brief"></iframe>